KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Acquisitions (2019 - 2021)

Biolife Solutions (BLFS) has disclosed Acquisitions for 3 consecutive years, with $1.5 million as the latest value for Q3 2021.

  • On a quarterly basis, Acquisitions rose 203.2% to $1.5 million in Q3 2021 year-over-year; TTM through Dec 2022 was $1.5 million, a 90.79% decrease, with the full-year FY2021 number at $1.6 million, down 89.57% from a year prior.
  • Acquisitions was $1.5 million for Q3 2021 at Biolife Solutions, down from $14.4 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $14.4 million in Q4 2020 to a low of -$13.7 million in Q3 2019.
  • A 3-year average of $3.3 million and a median of $1.5 million in 2021 define the central range for Acquisitions.
  • Peak YoY movement for Acquisitions: grew 5.53% in 2020, then surged 203.2% in 2021.
  • Biolife Solutions' Acquisitions stood at $13.7 million in 2019, then increased by 5.53% to $14.4 million in 2020, then plummeted by 89.51% to $1.5 million in 2021.
  • Per Business Quant, the three most recent readings for BLFS's Acquisitions are $1.5 million (Q3 2021), $14.4 million (Q4 2020), and $500000.0 (Q3 2020).